Amgen Net Working Capital from 2010 to 2026

AMG Stock  EUR 329.30  11.55  3.63%   
Amgen Net Working Capital yearly trend continues to be very stable with very little volatility. Net Working Capital is likely to drop to about 3.4 B. During the period from 2010 to 2026, Amgen Net Working Capital quarterly data regression pattern had sample variance of 288463883.4 T and median of  24,130,000,000. View All Fundamentals
 
Net Working Capital  
First Reported
2020-03-31
Previous Quarter
6.1 B
Current Value
3.6 B
Quarterly Volatility
8.2 B
 
Covid
 
Interest Hikes
Check Amgen financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Amgen's main balance sheet or income statement drivers, such as Tax Provision of 1.4 B, Interest Income of 218.9 M or Interest Expense of 1.7 B, as well as many indicators such as . Amgen financial statements analysis is a perfect complement when working with Amgen Valuation or Volatility modules.
  
This module can also supplement various Amgen Technical models . Check out the analysis of Amgen Correlation against competitors.
Evaluating Amgen's Net Working Capital across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Amgen Inc's fundamental strength.

Latest Amgen's Net Working Capital Growth Pattern

Below is the plot of the Net Working Capital of Amgen Inc over the last few years. It is Amgen's Net Working Capital historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Amgen's overall financial position and show how it may be relating to other accounts over time.
Net Working Capital10 Years Trend
Slightly volatile
   Net Working Capital   
       Timeline  

Amgen Net Working Capital Regression Statistics

Arithmetic Mean23,611,917,647
Geometric Mean16,212,068,547
Coefficient Of Variation71.93
Mean Deviation15,914,204,844
Median24,130,000,000
Standard Deviation16,984,224,546
Sample Variance288463883.4T
Range37.1B
R-Value(0.90)
Mean Square Error57727343.1T
R-Squared0.81
Slope(3,031,498,039)
Total Sum of Squares4615422134.6T

Amgen Net Working Capital History

20263.4 B
20253.6 B
20245.9 B
202311.9 B
20226.5 B
20217.2 B
20209.5 B

About Amgen Financial Statements

Amgen investors utilize fundamental indicators, such as Net Working Capital, to predict how Amgen Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Net Working Capital3.6 B3.4 B

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether Amgen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Amgen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Amgen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Amgen Inc Stock:
Check out the analysis of Amgen Correlation against competitors.
You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Understanding that Amgen's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Amgen represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Amgen's market price signifies the transaction level at which participants voluntarily complete trades.